参考文献/References:
[1] Miller K M, Ozinga S J,Rosenfeldt A B, et al.Quantifying turning behavior and gait in Parkinsons disease using mobile technology[J]. IBRO reports,2018,5(5):10-16.
[2] 林瑶,杨莎莎,刘婷,等.肉苁蓉对帕金森病模型大鼠PI3K、Akt、Bcl-2、Bax蛋白表达的影响[J].江西中医药大学学报,2019,31(1):83-86.
[3] 刘婷,杨莎莎,钟佳男,等.苁蓉精对帕金森病模型大鼠纹状体PI3K/AKT通路的影响[J].海峡药学,2019,31(3):8-11.
[4] 杨莎莎,覃威,陈诗雅,等.肉苁蓉对帕金森病模型大鼠行为学及海马组织干细胞增殖相关蛋白表达的影响[J].康复学报,2016,26(6):24-27,33.
[5] 田允,宋文婷,徐立,等.补肾中药对帕金森病模型小鼠黑质-纹状体多巴胺的影响[J].中国实验方剂学杂志,2011,17(1):134-137, 141.
[6] Cheng W L, Tzu Y L, Shu K H, et al.Echinacoside Inhibits Glutamate Release by Suppressing Voltage-Dependent Ca2+ Entry and Protein Kinase C in Rat Cerebrocortical Nerve Terminals[J].Int J Mol Sci,2016,17(7):1006.
[7] Dong L, Wang H, Niu J, et al.Echinacoside induces apoptotic cancer cell death by inhibiting the nucleotide pool sanitizing enzyme MTH1[J].OncoTargets and Therapy,2015,2015(Issue 1):3649-3664.
[8] You S P, Ma L, Zhao J, et al.Phenylethanol glycosides from cistanche tubμLosa suppress hepatic stellate cell activation and block the conduction of signaling pathways in TGF- β1/smad as potential anti-hepatic fibrosis agents [J].MolecμLes,2016,21(1):102.
[9] Chen M, Wang X D,Hu B,et al.Protective effects of echinacoside against anoxia/reperfusion injury in H9c2 cells via up-regμLating p-AKT and SLC8A3[J]. Biomedicine & Pharmacotherapy,2018,104(104):52-59.
[10] Camille B C, Richard K H W.Simvastatin as a Potential Disease-Modifying Therapy for Patients with Parkinsons Disease: Rationale for Clinical Trial, and Current Progress[J]. J Parkinsons Dis,2017,7(4): 545-568.
[11] 黄少东,梁健芬,陈月桥.中药复方辨证治疗帕金森病的临床和实验研究进展[J].中华中医药学刊,2019,37(5):1147-1150.
[12] 蔡晶,陈立典.杜建教授治疗帕金森病经验[J].中华中医药志,2010,25(11):1803-1805.
[13] 杨峻山.沙漠人参——肉苁蓉[J].中国药学杂志,2011,46(12):881.
[14] 解洪荣,张玉花,李雪松,等.MPTP/MPP+诱导的帕金森病实验模型的研究进展[J].医学综述,2011,17(5):669-672.
[15] 范振群,刘树民,周世慧,等.帕金森病体外细胞模型的研究进展[J].实验动物与比较医学,2013,33(1):74-78.
[16] 田林奇,韩颖,魏聪,等.两种不同细胞毒性检测方法的比较[J].中国医疗器械信息,2019,25(1):23-24,39.